Multicohort Study of Conditional Survival and Cause of Death After Achieving Event-Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL)

被引：0
|
作者：
Wang, Yucai [1 ]
Larson, Melissa [1 ]
Ekberg, Sara [2 ]
Smedby, Karin [2 ]
Zhao, Eric [3 ]
Gerrie, Alina [3 ]
Farooq, Umar [4 ]
Maurer, Matthew [1 ]
Paludo, Jonas [1 ]
Nowakowski, Grzegorz [1 ]
Habermann, Thomas [1 ]
Albertsson-Lindblad, Alexandra [5 ]
Glimelius, Ingrid [6 ]
Link, Brian [4 ]
Villa, Diego [3 ]
Jerkeman, Mats [5 ]
Cerhan, James [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Karolinska Inst, Stockholm, Sweden
[3] BC Canc, Vancouver, BC, Canada
[4] Univ Iowa, Iowa City, IA USA
[5] Lund Univ, Lund, Sweden
[6] Uppsala Univ, Uppsala, Sweden
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
mantle cell lymphoma; event-free survival at 24 months (EFS24); overall survival; cause of death;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MCL-063
引用
收藏
页码：S457 / S458
页数：2
相关论文
共 50 条
  • [41] Clinical and Quality of Life Predictors of Failure to Achieve Event Free Survival at 24 Months in Patients Aged 70 Years and Older with Diffuse Large B-Cell Lymphoma
    Reagan, Patrick M.
    Baran, Andrea M.
    Maurer, Matthew J.
    Feldman, Andrew L.
    Habermann, Thomas M.
    Slager, Susan L.
    Thanarajasingam, Gita
    Yost, Kathleen J.
    Link, Brian K.
    Cerhan, James R.
    Thompson, Carrie A.
    BLOOD, 2018, 132
  • [42] Early Relapse after First Line Has a Significant Impact on Overall Survival in Patients with Mantle Cell Lymphoma (MCL)
    Cabirta, Alba
    Abrisqueta, Pau
    Sanchez-Ruiz, Carla
    Bobillo, Sabela
    Carpio, Cecilia
    Iacoboni, Gloria
    Gironella Mesa, Mercedes
    Julia, Marta
    Serna, Angel
    Palacio, Carlos
    Castellvi, Josep
    Bosch, Francesc
    Marin-Niebla, Ana
    BLOOD, 2021, 138
  • [43] Progression-Free Survival at 24 Months as A Landmark After Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-cell Lymphoma
    Tun, Aung M.
    Maliske, Seth
    Wang, Yucai
    Inwards, David J.
    Habermann, Thomas M.
    Micallef, Ivana
    Porrata, Luis
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Rosenthal, Allison
    Kharfan-Dabaja, Mohamed A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 610 - 617
  • [44] A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study
    Ghesquieres, Herve
    Drouet, Youenn
    Slager, Susan L.
    Morschhauser, Franck
    Galimberti, Sara
    Robinson, Dennis P.
    Thomas, Emilie
    Novak, Anne J.
    Xerri, Luc
    Luminari, Stefano
    Verney, Aurelie
    Laurent, Camille
    Rimsza, Lisa M.
    Habermann, Thomas M.
    Federico, Massimo
    Link, Brian K.
    Salles, Gilles
    Cerhan, James R.
    BLOOD, 2022, 140 : 1307 - 1309
  • [45] Long-Term (≥4 Year and ≥5 Year) Overall Survival (OS) By 12-and 24-Month Event-Free Survival (EFS): An Updated Analysis of ZUMA-1, the Pivotal Study of Axicabtagene Ciloleucel (Axi- Cel) in Patients (Pts) with Refractory Large B-Cell Lymphoma (LBCL)
    Jacobson, Caron
    Locke, Frederick L.
    Ghobadi, Armin
    Miklos, David B.
    Lekakis, Lazaros J.
    Oluwole, Olalekan O.
    Lin, Yi
    Hill, Brian T.
    Timmerman, John M.
    Deol, Abhinav
    Reagan, Patrick M.
    Stiff, Patrick
    Flinn, Ian W.
    Farooq, Umar
    Goy, Andre H.
    Munoz, Javier
    Siddiqi, Tanya
    Shen, Rhine R.
    Bot, Adrian
    Dong, Jinghui
    Singh, Kanwarjit
    Spooner, Clare
    Karalliyadda, Roshan
    Kim, Jenny J.
    Zheng, Yan
    Neelapu, Sattva S.
    BLOOD, 2021, 138 : 1764 - +
  • [46] Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
    Maurer, M. J.
    Habermann, T. M.
    Shi, Q.
    Schmitz, N.
    Cunningham, D.
    Pfreundschuh, M.
    Seymour, J. F.
    Jaeger, U.
    Haioun, C.
    Tilly, H.
    Ghesquieres, H.
    Merli, F.
    Ziepert, M.
    Herbrecht, R.
    Flament, J.
    Fu, T.
    Flowers, C. R.
    Coiffier, B.
    ANNALS OF ONCOLOGY, 2018, 29 (08) : 1822 - 1827
  • [47] Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting
    van der Galien, H. T.
    Hoogendoorn, M.
    Kibbelaar, R. E.
    van Meerten, T.
    van Rijn, R. S.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 151 - 152
  • [48] Durable event-free and overall survival (EFS/OS) in mantle cell lymphoma (MCL) without rituximab: Long-term follow-up ofa phase II trial with intensive chemotherapy (CTAP/VMAC) followed by autologous hematopoietic stem cell transplant (aHSCT).
    Evens, Andrew M.
    Winter, Jane N.
    Hou, Nanjiang
    Rademaker, Fred
    Kelemen, Katalin
    Nelson, Beverly
    Patton, David
    Frankfurt, Olga
    Williams, Stephanie
    Singhal, Seema
    Tallman, Martin S.
    Rosen, Steven T.
    Mehta, Jayesh
    Gordon, Leo I.
    BLOOD, 2006, 108 (11) : 693A - 693A
  • [49] Early Relapse within 24 Months after Frontline Systemic Therapy (POD24) Is Associated with Worse Survival in Patients with Marginal Zone Lymphoma: A US Multisite Study
    Epperla, Narendranath
    Li, Rui
    Torka, Pallawi
    Shea, Lauren
    Karmali, Reem
    Anampa-Guzman, Andrea
    Oh, Timothy Seijung
    Lindsey, Kathryn
    Greenwell, Irl Brian
    Chowdhury, Sayan Mullick
    Annunzio, Kaitlin
    Christian, Beth
    Shouse, Geoffrey
    Herrera, Alex F.
    Bartlett, Nancy L.
    Grover, Natalie S.
    Olszewski, Adam J.
    BLOOD, 2022, 140 : 1926 - 1928
  • [50] Myeloablative radiochemotherapy followed by autologous blood stem cell transplantation leads to a significant prolongation of the event-free survival in patients with mantel cell lymphoma (MCL) -: Results of a prospective randomized European Intergroup study.
    Hiddemann, W
    Dreyling, M
    Pfreundschuh, M
    Gisselbrecht, C
    Diehl, V
    Boiron, JM
    Trümper, L
    Illiger, HJ
    Rudolph, C
    Boogaerts, M
    Kluin-Nelemans, H
    Parwaresch, R
    Unterhalt, M
    BLOOD, 2001, 98 (11) : 861A - 861A
12345